JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$9.74B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$8.51B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$6.03B |
| 4 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$4.86B |
| 5 |
Meta Platforms (Facebook)
META
|
+$4.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.63B |
| 2 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$3.02B |
| 3 |
Palantir
PLTR
|
+$2.14B |
| 4 |
Shopify
SHOP
|
+$2.1B |
| 5 |
Robinhood
HOOD
|
+$1.82B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 25.29% |
| 2 | Technology | 22.42% |
| 3 | Healthcare | 8.64% |
| 4 | Financials | 8.63% |
| 5 | Consumer Discretionary | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4201
WisdomTree US Multifactor Fund
USMF
$270M
| $1.4M | ﹤0.01% |
28,779
+1,755
| +6% | +$89.5K |
2022 Q4
13 quarters
|
|
|
NAGE
4202
Niagen Bioscience
NAGE
$221M
| $1.4M | ﹤0.01% |
326,711
-99,673
| -23% | -$538K |
2018 Q2
31 quarters
|
|
4203
Methanex
MEOH
$4.52B
| $1.4M | ﹤0.01% |
22,371
-55,592
| -71% | -$2.8M |
2015 Q2
43 quarters
|
|
4204
Pearson
PSO
$9.69B
| $1.4M | ﹤0.01% |
108,803
+46,446
| +74% | +$603K |
2014 Q3
46 quarters
|
|
4205
Marqeta
MQ
$1.72B
| $1.39M | ﹤0.01% |
86,498
-295,887
| -77% | -$4.98M |
2021 Q3
18 quarters
|
|
4206
Werner Enterprises
WERN
$2.12B
| $1.39M | ﹤0.01% |
48,648
-190,567
| -80% | -$6.18M |
2014 Q4
45 quarters
|
|
|
MNTN
4207
MNTN Inc
MNTN
$740M
| $1.39M | ﹤0.01% |
162,376
-181,137
| -53% | -$1.81M |
2025 Q3
2 quarters
|
|
|
ARDT
4208
Ardent Health
ARDT
$1.46B
| $1.39M | ﹤0.01% |
168,608
-70,109
| -29% | -$629K |
2024 Q3
6 quarters
|
|
|
HOLA
4209
JPMorgan International Hedged Equity Laddered Overlay ETF
HOLA
$274M
| $1.39M | ﹤0.01% |
27,037
+16,743
| +163% | +$898K |
2025 Q4
1 quarter
|
|
4210
Ameresco
AMRC
$1.14B
| $1.39M | ﹤0.01% |
56,154
+36,178
| +181% | +$1.08M |
2017 Q4
33 quarters
|
|
4211
Dimensional Global Credit ETF
DGCB
$1.1B
| $1.39M | ﹤0.01% |
25,816
+19,292
| +296% | +$1.05M |
2024 Q2
7 quarters
|
|
4212
iShares Global REIT ETF
REET
$4.62B
| $1.39M | ﹤0.01% |
55,928
-3,404
| -6% | -$88.4K |
2020 Q2
23 quarters
|
|
4213
Fidelity MSCI Materials Index ETF
FMAT
$573M
| $1.39M | ﹤0.01% |
24,609
-8,862
| -26% | -$519K |
2022 Q4
13 quarters
|
|
4214
CALL
Exelixis
EXEL
$14.5B
| $1.38M | ﹤0.01% |
33,000
| – | – |
2025 Q4
1 quarter
|
|
4215
ArriVent BioPharma
AVBP
$1.39B
| $1.38M | ﹤0.01% |
65,879
-3,515
| -5% | -$79.4K |
2024 Q1
8 quarters
|
|
4216
Ceco Environmental
CECO
$4.31B
| $1.38M | ﹤0.01% |
24,256
+1,433
| +6% | +$92.2K |
2016 Q4
37 quarters
|
|
|
PPIH
4217
Perma-Pipe International
PPIH
$261M
| $1.37M | ﹤0.01% |
48,721
+16,969
| +53% | +$523K |
2023 Q3
10 quarters
|
|
|
ALUB
4218
Alussa Energy Acquisition Corp II
ALUB
$364M
| $1.37M | ﹤0.01% |
+137,682
| New | +$1.38M |
2026 Q1
0 quarters
|
|
4219
CALL
Liquidia Corp
LQDA
$2.56B
| $1.37M | ﹤0.01% |
+39,000
| New | +$1.45M |
2026 Q1
0 quarters
|
|
|
4220
PUT
Liquidia Corp
LQDA
$2.56B
| $1.37M | ﹤0.01% |
+39,000
| New | +$1.45M |
2026 Q1
0 quarters
|
|
4221
Astrana Health
ASTH
$1.78B
| $1.37M | ﹤0.01% |
56,191
+588
| +1% | +$13.9K |
2018 Q2
31 quarters
|
|
4222
Arcturus Therapeutics
ARCT
$370M
| $1.36M | ﹤0.01% |
197,815
-8,354
| -4% | -$61K |
2019 Q2
27 quarters
|
|
|
MFA
4223
MFA Financial
MFA
$773M
| $1.36M | ﹤0.01% |
141,257
+9,487
| +7% | +$93.5K |
2013 Q2
51 quarters
|
|
|
WHR.PRA
4224
Whirlpool Corp 8.50% Series A Preferred Stock
WHR.PRA
| $1.36M | ﹤0.01% |
+33,200
| New | +$1.42M |
2026 Q1
0 quarters
|
|
4225
CALL
Las Vegas Sands
LVS
$23.5B
| $1.36M | ﹤0.01% |
26,300
-180,000
| -87% | -$10.2M |
2022 Q2
15 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2026 Portfolio in Review
As of Q1 2026, JP Morgan Chase held 8,085 positions worth $1.56T, down 2.2% from $1.59T the previous quarter. Its ten largest holdings account for 23% of the portfolio.
JP Morgan Chase deployed $90.5B of net new capital in Q1 2026, opening 727 new positions and adding to 3,199 existing holdings. Its largest new stake was iShares International Country Rotation Active ETF: 15,443,505 shares worth $481M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 25% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Microsoft, an estimated $8.63B trimmed.
- JP Morgan Chase's largest Q1 2026 buy was iShares International Country Rotation Active ETF: 15,443,505 shares worth $481M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2026, an estimated $9.74B increase.
- JP Morgan Chase's biggest Q1 2026 reduction was Microsoft, cutting an estimated $8.63B.
- JP Morgan Chase fully exited CyberArk in Q1 2026, selling an estimated $307M.
- JP Morgan Chase's ten largest holdings make up 23% of its $1.56T portfolio in Q1 2026.
- JP Morgan Chase opened 727 new positions and closed 604 in Q1 2026.
- JP Morgan Chase's portfolio value fell 2.2% quarter-over-quarter to $1.56T.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.